Compare MTW & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTW | NAUT |
|---|---|---|
| Founded | 1902 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.9M | 383.5M |
| IPO Year | 1994 | 2020 |
| Metric | MTW | NAUT |
|---|---|---|
| Price | $13.27 | $3.00 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $10.50 | $4.00 |
| AVG Volume (30 Days) | 184.2K | ★ 418.4K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $2,240,900,000.00 | N/A |
| Revenue This Year | $4.73 | N/A |
| Revenue Next Year | $2.98 | $992.86 |
| P/E Ratio | $65.45 | ★ N/A |
| Revenue Growth | ★ 2.89 | N/A |
| 52 Week Low | $7.28 | $0.62 |
| 52 Week High | $15.56 | $4.31 |
| Indicator | MTW | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 48.41 |
| Support Level | $12.30 | $1.93 |
| Resistance Level | $13.32 | $3.08 |
| Average True Range (ATR) | 0.45 | 0.38 |
| MACD | 0.25 | -0.09 |
| Stochastic Oscillator | 95.79 | 11.49 |
Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.